Envista Holdings Corporation (NVST)
NYSE: NVST · IEX Real-Time Price · USD
16.57
+0.07 (0.42%)
At close: Jul 19, 2024, 4:00 PM
16.58
+0.01 (0.06%)
Pre-market: Jul 22, 2024, 4:46 AM EDT
Envista Holdings Revenue
Envista Holdings had revenue of $2.56B in the twelve months ending March 29, 2024. Revenue in the quarter ending March 29, 2024 was $623.60M. In the year 2023, Envista Holdings had annual revenue of $2.57B.
Revenue (ttm)
$2.56B
Revenue Growth
-0.08%
P/S Ratio
1.11
Revenue / Employee
$200,227
Employees
12,800
Market Cap
2.85B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.57B | -2.60M | -0.10% |
Dec 31, 2022 | 2.57B | 60.20M | 2.40% |
Dec 31, 2021 | 2.51B | 579.80M | 30.06% |
Dec 31, 2020 | 1.93B | -355.70M | -15.57% |
Dec 31, 2019 | 2.28B | -559.70M | -19.68% |
Dec 31, 2018 | 2.84B | 33.60M | 1.20% |
Dec 31, 2017 | 2.81B | 25.50M | 0.92% |
Dec 31, 2016 | 2.79B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
agilon health | 4.78B |
ICU Medical | 2.26B |
LivaNova | 1.19B |
ACADIA Pharmaceuticals | 813.81M |
Tandem Diabetes Care | 770.01M |
Azenta | 651.76M |
MorphoSys AG | 264.75M |
Rhythm Pharmaceuticals | 91.93M |
NVST News
- 6 days ago - Envista Holdings Corporation Announces Key Leadership Appointments - PRNewsWire
- 9 days ago - Envista Schedules Second Quarter 2024 Earnings Call - PRNewsWire
- 6 weeks ago - Envista Smile Project Seeks to Advance Oral Care for Underserved Communities Through $2.1 Million Donation to the University of Southern California's Herman Ostrow School of Dentistry - PRNewsWire
- 2 months ago - Envista Announces Participation in Stifel Jaws & Paws Conference - PRNewsWire
- 2 months ago - Envista Reports First Quarter 2024 Results - PRNewsWire
- 3 months ago - Envista Announces CEO Appointment - PRNewsWire
- 3 months ago - Envista Smile Project Donates $1.2 Million in 2023 - PRNewsWire
- 3 months ago - Envista Schedules First Quarter 2024 Earnings Call - PRNewsWire